Relay Therapeutics (RLAY) Upgraded by Oppenheimer, Price Target Set at $14

 Relay Therapeutics (RLAY) received a significant upgrade from Oppenheimer today, elevating its rating from "Perform" to "Outperform." Analyst Matthew Biegler announced a new price target of $14.00 for the stock.

https://www.gurufocus.com/news/8551639/relay-therapeutics-rlay-upgraded-by-oppenheimer-price-target-set-at-1400-rlay-stock-news